POC Diagnostics Market

Point-of-care Diagnostics (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.

POC Diagnostics Market contains market size and forecasts of POC Diagnostics in global, including the following market information:

Global POC Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global POC Diagnostics Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five POC Diagnostics companies in 2021 (%)

The global POC Diagnostics market was valued at 26410 million in 2021 and is projected to reach US$ 48270 million by 2028, at a CAGR of 9.0% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Blood Glucose Testing Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of POC Diagnostics include Alere, Roche, Abbott Laboratories, Johnson & Johnson, Siemens Healthcare, Danaher, Bayer Healthcare, Beckman Coulter and Nipro Diagnostics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the POC Diagnostics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global POC Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global POC Diagnostics Market Segment Percentages, by Type, 2021 (%)

Blood Glucose Testing

Infectious Diseases Testing

Cardiac Markers Testing

Coagulation Testing

Pregnancy and Fertility Testing

Blood Gas or Electrolytes Testing

Tumor Markers Testing

Urinalysis Testing

Cholesterol Testing

Others

Global POC Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global POC Diagnostics Market Segment Percentages, by Application, 2021 (%)

Clinics

Hospitals

Laboratory

Others

Global POC Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global POC Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies POC Diagnostics revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies POC Diagnostics revenues share in global market, 2021 (%)

Key companies POC Diagnostics sales in global market, 2017-2022 (Estimated), (K Units)

Key companies POC Diagnostics sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Alere

Roche

Abbott Laboratories

Johnson & Johnson

Siemens Healthcare

Danaher

Bayer Healthcare

Beckman Coulter

Nipro Diagnostics

Bio-Rad Laboratories

Nova Biomedical

BioMerieux

Quidel

Helena Laboratories

OraSure Technologies

Accriva

Abaxis

Chembio Diagnostics

Trinity Biotech